Ryan Urak

1.9k total citations · 1 hit paper
31 papers, 1.1k citations indexed

About

Ryan Urak is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Ryan Urak has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 15 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in Ryan Urak's work include CAR-T cell therapy research (27 papers), Immune Cell Function and Interaction (8 papers) and Viral Infectious Diseases and Gene Expression in Insects (7 papers). Ryan Urak is often cited by papers focused on CAR-T cell therapy research (27 papers), Immune Cell Function and Interaction (8 papers) and Viral Infectious Diseases and Gene Expression in Insects (7 papers). Ryan Urak collaborates with scholars based in United States, Australia and Brazil. Ryan Urak's co-authors include Stephen J. Forman, Xiuli Wang, Christine E. Brown, Renate Starr, Xin Yang, Laura Lim, ChingLam W. Wong, Sandra H. Thomas, Miriam Walter and Brenda Aguilar and has published in prestigious journals such as Nucleic Acids Research, Blood and Cancer Research.

In The Last Decade

Ryan Urak

29 papers receiving 1.1k citations

Hit Papers

IL15 Enhances CAR-T Cell Antitumor Activity by Reducing m... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan Urak United States 15 910 425 402 301 254 31 1.1k
ChingLam W. Wong United States 7 944 1.0× 359 0.8× 381 0.9× 312 1.0× 323 1.3× 8 1.0k
Chuang Sun United States 15 870 1.0× 389 0.9× 390 1.0× 329 1.1× 232 0.9× 18 1.1k
Virna Marin Italy 14 948 1.0× 338 0.8× 534 1.3× 217 0.7× 374 1.5× 26 1.1k
Yinmeng Yang United States 9 662 0.7× 338 0.8× 325 0.8× 174 0.6× 210 0.8× 18 877
Scott E. James United States 9 1.0k 1.1× 374 0.9× 482 1.2× 304 1.0× 392 1.5× 12 1.2k
Simon Thomas United Kingdom 10 677 0.7× 279 0.7× 201 0.5× 266 0.9× 215 0.8× 28 773
Aruna Mahendravada United States 7 1.2k 1.3× 368 0.9× 544 1.4× 442 1.5× 419 1.6× 15 1.3k
Connie P.M. Duong United States 15 1.1k 1.2× 379 0.9× 683 1.7× 259 0.9× 313 1.2× 24 1.4k
Jessica Hartmann Germany 16 864 0.9× 471 1.1× 483 1.2× 168 0.6× 379 1.5× 25 1.2k
Mary A. Black United States 11 1.1k 1.3× 478 1.1× 681 1.7× 206 0.7× 295 1.2× 16 1.3k

Countries citing papers authored by Ryan Urak

Since Specialization
Citations

This map shows the geographic impact of Ryan Urak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Urak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Urak more than expected).

Fields of papers citing papers by Ryan Urak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Urak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Urak. The network helps show where Ryan Urak may publish in the future.

Co-authorship network of co-authors of Ryan Urak

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Urak. A scholar is included among the top collaborators of Ryan Urak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Urak. Ryan Urak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Anthony K., Isabel Monroy, Yuwei Ren, et al.. (2025). Universal off-the-shelf combination immunotherapy using oncolytic viruses to redirect T cell engagers to target solid tumors. Journal for ImmunoTherapy of Cancer. 13(8). e011051–e011051.
2.
Urak, Ryan, et al.. (2025). Capivasertib enhances chimeric antigen receptor T cell activity in preclinical models of B cell lymphoma. Molecular Therapy — Methods & Clinical Development. 33(1). 101421–101421.
3.
Stern, Lawrence A., Vibhuti Vyas, Laura Lim, et al.. (2024). Development and characterization of a low-affinity humanized CD19 chimeric antigen receptor for B-cell malignancies. PubMed. 1(4). 100048–100048. 2 indexed citations
4.
Goldberg, Lior, Ryan Urak, Vibhuti Vyas, et al.. (2024). Immunometabolic Adaptation of CD19-Targeted CAR T Cells in the Central Nervous System Microenvironment of Patients Promotes Memory Development. Cancer Research. 84(7). 1048–1064. 4 indexed citations
5.
Urak, Ryan, Nicole Grepo, Lior Goldberg, et al.. (2023). Evaluation of the Elements of Short Hairpin RNAs in Developing shRNA-Containing CAR T Cells. Cancers. 15(10). 2848–2848. 2 indexed citations
6.
Awuah, Dennis, Lin Li, Lindsay A. Williams, et al.. (2023). Ex-vivo CS1-OKT3 dual specific bivalent antibody-armed effector T cells mediate cellular immunity against multiple myeloma. Scientific Reports. 13(1). 20853–20853. 1 indexed citations
7.
Urak, Ryan, Dennis Awuah, Vibhuti Vyas, et al.. (2023). Dexamethasone potentiates chimeric antigen receptor T cell persistence and function by enhancing IL-7Rα expression. Molecular Therapy. 32(2). 527–539. 10 indexed citations
8.
Awuah, Dennis, Lawrence A. Stern, Joseph R. Cohen, et al.. (2021). Developing a Safer Anti-CD44v6 Chimeric Antigen Receptor T Cell Against Hematological Cancers By Mitigating on-Target Off-Tumor Toxicity. Blood. 138(Supplement 1). 2796–2796. 2 indexed citations
9.
Urak, Ryan, Roslyn M. Ray, Tristan Scott, et al.. (2020). Conditionally Replicating Vectors Mobilize Chimeric Antigen Receptors against HIV. Molecular Therapy — Methods & Clinical Development. 19. 285–294. 6 indexed citations
10.
Alizadeh, Darya, Robyn A. Wong, Xin Yang, et al.. (2019). IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype. Cancer Immunology Research. 7(5). 759–772. 324 indexed citations breakdown →
11.
Scott, Tristan, et al.. (2019). Improved Cas9 activity by specific modifications of the tracrRNA. Scientific Reports. 9(1). 16104–16104. 22 indexed citations
12.
Waters, Shafagh A., Tristan Scott, Sheena Saayman, et al.. (2019). Targeted Activation of Cystic Fibrosis Transmembrane Conductance Regulator. Molecular Therapy. 27(10). 1737–1748. 27 indexed citations
13.
Wang, Xiuli, Miriam Walter, Ryan Urak, et al.. (2019). Large-Scale Manufacturing of CMV-CD19CAR T Cells and Characterization of Their Biologic and Immunologic Properties. Blood. 134(Supplement_1). 3247–3247. 1 indexed citations
14.
Wang, Xiuli, Miriam Walter, Ryan Urak, et al.. (2017). Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor–Redirected T Cells Against Multiple Myeloma. Clinical Cancer Research. 24(1). 106–119. 149 indexed citations
15.
Priceman, Saul J., Ethan Gerdts, Dileshni Tilakawardane, et al.. (2017). Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer. OncoImmunology. 7(2). e1380764–e1380764. 120 indexed citations
16.
Urak, Ryan, Miriam Walter, Laura Lim, et al.. (2017). Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy. Journal for ImmunoTherapy of Cancer. 5(1). 26–26. 85 indexed citations
17.
Pagliaccia, Deborah, et al.. (2017). Genetic Structure of the Rice Blast Pathogen (Magnaporthe oryzae) over a Decade in North Central California Rice Fields. Microbial Ecology. 75(2). 310–317. 16 indexed citations
18.
Rosenzweig, Michael, Ryan Urak, Miriam Walter, et al.. (2017). Preclinical data support leveraging CS1 chimeric antigen receptor T-cell therapy for systemic light chain amyloidosis. Cytotherapy. 19(7). 861–866. 23 indexed citations
19.
Wang, Xiuli, ChingLam W. Wong, Ryan Urak, et al.. (2015). CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells. Clinical Cancer Research. 21(13). 2993–3002. 52 indexed citations
20.
Jonnalagadda, Mahesh, Armen Mardiros, Ryan Urak, et al.. (2014). Chimeric Antigen Receptors With Mutated IgG4 Fc Spacer Avoid Fc Receptor Binding and Improve T Cell Persistence and Antitumor Efficacy. Molecular Therapy. 23(4). 757–768. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026